GUTS logo

Fractyl Health (GUTS)

Profile

Full Name

Fractyl Health, Inc.

Ticker Symbol

GUTS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://fractyl.com

Employees

107

Key Details

Price

$1.01(+0.49%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$93.00K(-22.50% YoY)

Annual EPS

-$1.62(+18.28% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.01
GUTS price is $1.01

30-Day Relative Volume

1.18
GUTS 30-day relative volume is 1.18

Price Performance

Price Today change

+0.49%
GUTS price is up +0.49% today

Price YTD change

-50.73%
GUTS price is down -50.73% since January 1st

Price 1-year change

-84.41%
GUTS price is down -84.41% year-on-year

Price 3-year change

-
GUTS price 3-year change is unknown

Price Range

Price All-time high

$14.50
GUTS price is currently -93.00% below its historical high of $14.50

Price 3-year low

$0.87
GUTS price is currently +16.25% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$49.65M
GUTS market capitalization is $49.65 million

Market cap 3-year change

-
GUTS market capitalization 3-year change is unknown

Market cap All-time high

$611.75M
GUTS market capitalization is currently -91.88% below its historical high of $611.75 million

Market cap sector rank

38.46%
GUTS market capitalization is higher than 38.46% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.14%
GUTS shares outstanding is up +2.14% year-on-year

Shares Outstanding 3-Year Change

-
GUTS shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.78
GUTS beta is 0.78

200-day SMA

$2.38
GUTS price is currently -57.38% below its 200-day simple moving average

50-day SMA

$1.36
GUTS price is currently -25.62% below its 50-day simple moving average

RSI

33.75
GUTS 14-day relative strength index is 33.75

Volume

1.18
GUTS 30-day relative volume is 1.18

ATR

$0.11
GUTS average true range is $0.11

10-day Historical Volatility

72.00%
GUTS 10-day historical volatility is 72.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$93.00K
GUTS annual revenue is $93.00 thousand

Revenue Analysts estimate

-
GUTS annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-22.5%
GUTS annual revenue is down -22.5% year-on-year

Revenue Sector rank

5.04%
GUTS annual revenue is higher than 5.04% of companies in Healthcare sector

EPS

EPS

-$1.62
GUTS annual earnings per share is -$1.62

EPS Analysts estimate

-$1.42
GUTS annual earnings per share is currently +14.08% higher than the consensus analysts' forecast

EPS 1-year change

+18.28%
GUTS annual earnings per share is up +18.28% year-on-year

EPS Sector rank

43.44%
GUTS annual earnings per share is higher than 43.44% of companies in Healthcare sector

Profit

Gross profit

$43.00K
GUTS annual gross profit is $43.00 thousand

Gross margin

46.24%
GUTS annual gross profit margin is 46.24%

Operating profit

-$93.53M
GUTS annual operating income is -$93.53 million

Operating margin

-100.57K%
GUTS annual operating profit margin is -100.57 thousand%

Net income

-$68.69M
GUTS annual net profit is -$68.69 million

Net margin

-73.86K%
GUTS annual net profit margin is -73.86 thousand%

Expenses

Total expenses

$93.62M
GUTS annual total expenses is $93.62 million

Operating expenses

$93.57M
GUTS annual total operating expenses is $93.57 million

Cost of goods sold

$50.00K
GUTS annual cost of goods sold is $50.00 thousand

Selling, general & administrative expenses

$23.10M
GUTS annual SGA is $23.10 million

Depreciation and amortization

$677.00K
GUTS annual depreciation & amortization is $677.00 thousand

Interest expense

-
GUTS annual interest expense value is unknown

Income tax

-
GUTS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$93.53M
GUTS annual earnings before interest & taxes is -$93.53 million

EBITDA

-$92.85M
GUTS annual EBITDA is -$92.85 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$108.08M
GUTS annual total assets is $108.08 million

Non current assets

$36.31M
GUTS annual long term assets is $36.31 million

Current assets

$71.76M
GUTS annual total current assets is $71.76 million

Cash and cash equivalents

$67.46M
GUTS annual cash & cash equivalents is $67.46 million

Accounts receivable

$0.00
GUTS annual accounts receivable is $0.00

Inventory

$73.00K
GUTS annual inventory is $73.00 thousand

Liabilities

Total liabilities

$79.65M
GUTS annual total liabilities is $79.65 million

Long term liabilities

$59.88M
GUTS annual total long term liabilities is $59.88 million

Current liabilities

$19.77M
GUTS annual total current liabilities is $19.77 million

Accounts payable

$3.24M
GUTS annual accounts payable is $3.24 million

Debt

Total debt

$62.50M
GUTS annual total debt is $62.50 million

Total debt 1-year change

-27.65%
GUTS annual total debt is down -27.65% year-on-year

Long term debt

$57.54M
GUTS annual long term debt is $57.54 million

Short term debt

$4.96M
GUTS annual short term debt is $4.96 million

Equity & Capital

Shareholders equity

$28.42M
GUTS annual stockholders equity is $28.42 million

Book value

$28.42M
GUTS annual book value is $28.42 million

Retained earnings

-$415.31M
GUTS annual retained earnings is -$415.31 million

Working capital

$51.99M
GUTS annual working capital is $51.99 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$65.52M
GUTS annual cash flow from operations is -$65.52 million

Cash from operations 1-year change

-53%
GUTS annual cash flow from operations is down -53% year-on-year

Cash from investing

-$1.76M
GUTS annual cash flow from investing activities is -$1.76 million

Cash from investing 1-year change

-391.64%
GUTS annual cash flow from investing activities is down -391.64% year-on-year

Cash from financing

$101.23M
GUTS annual cash flow from financing activities is $101.23 million

Cash from financing 1-year change

+268.94%
GUTS annual cash flow from financing activities is up +268.94% year-on-year

CAPEX

CAPEX

$1.76M
GUTS annual capital expenditures is $1.76 million

CAPEX 1-year change

+391.64%
GUTS annual capital expenditures is up +391.64% year-on-year

Free Cash Flow

Free cash flow

-$67.29M
GUTS annual free cash flow is -$67.29 million

Free cash flow 1-year change

-55.82%
GUTS annual free cash flow is down -55.82% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

46.24%
GUTS annual gross profit margin is 46.24%

Operating margin

-100.57K%
GUTS annual operating profit margin is -100.57 thousand%

Net margin

-73.86K%
GUTS annual net profit margin is -73.86 thousand%

ROA & ROE

ROA

-74.55%
GUTS annual return on assets is -74.55%

ROE

-241.68%
GUTS annual return on equity is -241.68%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GUTS price to earnings ratio value is unknown

PE ratio Sector rank

-
GUTS price to earnings ratio is unknown

PB Ratio

PB ratio

1.75
GUTS price to book ratio is 1.75

PB ratio Sector rank

59.38%
GUTS price to book ratio is higher than 59.38% of companies in Healthcare sector

PS Ratio

PS ratio

533.86
GUTS price to sales ratio is 533.86

PS ratio Sector rank

97.95%
GUTS price to sales ratio is higher than 97.95% of companies in Healthcare sector

Enterprise value

Enterprise value

$44.69M
GUTS enterprise value is $44.69 million

Enterprise value Sector rank

40.79%
GUTS enterprise value is higher than 40.79% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.48
GUTS EV/EBITDA is -0.48

EV/EBITDA Sector rank

51.95%
GUTS EV/EBITDA is higher than 51.95% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.63
GUTS annual current ratio is 3.63

Quick ratio

3.63
GUTS annual quick ratio is 3.63

Leverage

Debt to equity

1.06
GUTS annual debt to equity ratio is 1.06

Interest coverage ratio

-
GUTS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
GUTS piotroski f-score value is unknown

Altman Z-Score

-7.28
GUTS altman z-score is -7.28

Analyst ratings

Recent major analysts updates

Feb 3, 25 Morgan Stanley
Overweight
Feb 28, 24 Evercore ISI Group
Outperform
Feb 27, 24 Morgan Stanley
Overweight

Institutional Ownership

Similar stocks

ALVR logo
AlloVir (ALVR)
CYCC logo
Cyclacel Pharmaceuticals (CYCC)
VTVT logo
vTv Therapeutics (VTVT)
ZOM logo
Zomedica (ZOM)
ICAD logo
iCAD (ICAD)
SER logo
Serina Therapeutics (SER)
ICCC logo
ImmuCell (ICCC)
STRO logo
Sutro Biopharma (STRO)
CCLD logo
CareCloud (CCLD)
  • What is the ticker symbol for Fractyl Health?
  • Does Fractyl Health pay dividends?
  • What sector is Fractyl Health in?
  • What industry is Fractyl Health in?
  • What country is Fractyl Health based in?
  • Is Fractyl Health in the S&P 500?
  • Is Fractyl Health in the NASDAQ 100?
  • Is Fractyl Health in the Dow Jones?
  • When was Fractyl Health's last earnings report?
  • When does Fractyl Health report earnings?
  • Should I buy Fractyl Health stock now?

What is the ticker symbol for Fractyl Health?

The ticker symbol for Fractyl Health is NASDAQ:GUTS

Does Fractyl Health pay dividends?

No, Fractyl Health does not pay dividends

What sector is Fractyl Health in?

Fractyl Health is in the Healthcare sector

What industry is Fractyl Health in?

Fractyl Health is in the Biotechnology industry

What country is Fractyl Health based in?

Fractyl Health is headquartered in United States

Is Fractyl Health in the S&P 500?

No, Fractyl Health is not included in the S&P 500 index

Is Fractyl Health in the NASDAQ 100?

No, Fractyl Health is not included in the NASDAQ 100 index

Is Fractyl Health in the Dow Jones?

No, Fractyl Health is not included in the Dow Jones index

When was Fractyl Health's last earnings report?

Fractyl Health's most recent earnings report was on Mar 3, 2025

When does Fractyl Health report earnings?

The next expected earnings date for Fractyl Health is May 13, 2025

Should I buy Fractyl Health stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page